mifepristone has been researched along with tamoxifen in 134 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (15.67) | 18.7374 |
| 1990's | 51 (38.06) | 18.2507 |
| 2000's | 38 (28.36) | 29.6817 |
| 2010's | 24 (17.91) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hollenberg, PF; Johnson, WW; Lin, HL; Medower, C; Zhang, H | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, C; Du, X; Eksterowicz, J; Fantin, VR; Huang, E; Huang, T; Jackson, E; Jahchan, N; Kawai, H; McGee, LR; Medina, JC; Rew, Y; Sun, D; Sutimantanapi, D; Waszczuk, J; Yan, X; Ye, Q; Zavorotinskaya, T; Zhou, H; Zhu, L | 1 |
| Wakeling, AE | 1 |
| Monet, JD; Thomas, M | 1 |
| Gronemeyer, H | 1 |
| Bélanger, L; Bocquel, MT; Chambon, P; Meyer, ME; Turcotte, B | 1 |
| Ruh, MF; Ruh, TS; Turner, JW; Ward, DT | 1 |
| Petraglia, F; Vale, W; Vaughan, J | 1 |
| Bakker, GH; De Jong, FH; Foekens, JA; Klijn, JG; Portengen, H; Setyono-Han, B | 2 |
| Bygdeman, M; Gemzell, K; Swahn, ML | 1 |
| Bader, C; Monet, JD; Thomas, M | 1 |
| Gompel, A; Kuttenn, F; Malet, C; Mauvais-Jarvis, P | 2 |
| Croxatto, HB; Croxatto, HD; Salvatierra, AM; Spitz, IM | 1 |
| Blankenstein, MA; Thijssen, JH; van der Meulen-Dijk, C | 1 |
| Cabrera, RR; De Vito, E; Guardia, DC | 1 |
| Assailly, J; Bader, CA; Brami, M; Dautigny, N; Monet, JD; Thomas, M; Ulmann, A | 1 |
| Mazella, J; Sun, B; Tseng, L | 1 |
| Baulieu, EE; Jung-Testas, I | 2 |
| Jordan, VC; Robinson, SP | 1 |
| Chambon, P; Green, S; Jin, JR; Webster, NJ | 1 |
| Beck, G; Chasserot-Golaz, S | 1 |
| Lamberts, SW; van Koetsveld, P; Verleun, T | 1 |
| Atger, M; Milgrom, E; Misrahi, M | 1 |
| Astinotti, D; Chambon, P; Dierich, A; Gaub, MP; Touitou, I | 1 |
| Balthazart, J; Delville, Y | 1 |
| Baulieu, EE; Garcia, T; Jung-Testas, I | 1 |
| Beck, DW; Loh, PM; Olson, JJ; Schlechte, J | 1 |
| Baulieu, E | 1 |
| Bardon, S; Montcourrier, P; Rochefort, H; Vignon, F | 1 |
| Loosfelt, H; Milgrom, E; Philibert, D; Rauch, M | 1 |
| Prasad, KS; Rao, AJ; Sharma, SC; Subbarayan, VS | 1 |
| Deis, RP; Telleria, CM | 1 |
| Aguilar, R; Bellido, C; Sánchez-Criado, JE; Tébar, M | 1 |
| Gravanis, A; Makrigiannakis, A; Margioris, AN; Stournaras, C | 1 |
| Chang, TJ; Chang, YF; Chi, CW; Lui, WY; P'Eng, FK; Wu, CW; Yeh, TH | 1 |
| Chien, CH; Hamilton, TC; Wang, FF | 1 |
| Bygdeman, M; Gemzell-Danielsson, K; Svalander, P; Swahn, ML | 1 |
| Bygdeman, M; Danielsson, KG; Mäentausta, O; Svalander, P; Vihko, R | 1 |
| Deis, RP; Jahn, GA; Rastrilla, AM | 1 |
| Manning, DL; Nicholson, RI | 1 |
| Bygdeman, M; Cekan, S; Johannisson, E; Seppälä, M; Swahn, ML | 1 |
| Bellido, C; Galiot, F; Gonzalez, D; Sánchez-Criado, JE; Tébar, M | 1 |
| Barnea, ER; Rose, FV | 1 |
| Bell, SC; Sadek, S | 1 |
| Bardin, CW; Kaplan-Kraicer, R; Kostovetsky, I; Shalgi, R | 1 |
| Daxenbichler, G; Hofstädter, F; Marth, C; Müller-Holzner, E; Zeimet, AG | 1 |
| Bhargava, VL; Bhatla, N; Farooq, A; Murugesan, K; Periwal, SB; Vij, U | 1 |
| Bardin, CW; Dao, B; Koide, SS; Marshall, A; Vanage, G | 1 |
| Aguilar, R; Gaytán, F; Ruiz, A; Sánchez-Criado, JE; Tébar, AM | 1 |
| Bieńkiewicz, A; Kuś, E; Welfel, J | 1 |
| Koide, SS; Li, XJ; Yu, H | 1 |
| Nedvídková, J; Schreiber, V; Stárka, L | 1 |
| Gurpide, E; Markiewicz, L | 1 |
| Deis, RP; Soaje, M | 1 |
| Lenz, T | 1 |
| Chi, CW; Ho, CK; Wang, SY; Yu, KJ | 1 |
| Bagchi, MK; Jeyakumar, M; Petukhov, S; Zhang, X | 1 |
| Kimmick, GG; Muss, HB | 1 |
| Rai, U | 1 |
| El Etreby, MF; Liang, Y | 1 |
| Jeong, HG; Lee, SS; Yang, KH | 1 |
| Fang, X; Mitchell, BF; Wong, S | 2 |
| Coe, JE; Ishak, KG; Ross, MJ | 1 |
| Budel, V; Cahen, P; Chaboteaux, C; Darro, F; Decaestecker, C; Kiss, R; Leblond, B; Nogaret, JM; Pétein, M; Pourrias, B; Ramos, C; Schoofs, A; Vianna, A | 1 |
| El Etreby, MF; Liang, Y; Schoenlein, PV; Wrenn, RW | 1 |
| Arici, A; Bahtiyar, MO; Kim, G; Seli, E; Senturk, LM | 1 |
| Chang, CY; Christensen, DJ; Fan, D; Fowlkes, DM; Hamilton, PT; Huacani, MR; McDonnell, DP; Norris, JD; Paige, LA | 1 |
| Cabot, MC; Giuliano, AE; Han, TY; Liu, YY; Lucci, A | 1 |
| Alalami, O; Martin, JH; van den Berg, HW | 1 |
| Cao, L; Gu, ZP; Leng, Y; Yang, B | 1 |
| Kangawa, K; Makino, I; Makino, Y; Shibata, K | 1 |
| El Etreby, MF; Lewis, RW; Liang, Y | 1 |
| Kass, L; Luque, EH; Montes, GS; Muñoz de Toro, M; Ramos, JG; Rodriguez, H; Varayoud, J | 1 |
| Budziszewska, B; Jaworska-Feil, L; Kajta, M; Lasoń, W | 1 |
| Aguilar, R; Alonso, R; Bellido, C; Garrido-Gracia, JC; González, D; Hernández, G; Sánchez-Criado, JE | 1 |
| Csaba, G; Inczefi-Gonda, A | 1 |
| Vastag, B | 1 |
| Gaston, K; Taylor, A; Webster, K | 1 |
| Bain, DL; Graham, JD; Horwitz, KB; Jackson, TA; Richer, JK; Tung, L | 1 |
| Aldaghlas, TA; Holleran, AL; Kelleher, JK; Lindenthal, B; Ruan, B; Schroepfer, GJ; Wilson, WK | 1 |
| Csaba, G; Karabélyos, C | 1 |
| Ali, AA; El Etreby, MF; Kumar, MV; Lewis, RW; Liang, Y; Sridhar, S | 1 |
| de Di Nasso, EG; Deis, RP; Soaje, M | 1 |
| Auewarakul, P; Cid-Arregui, A; García-Carrancá, A; Juárez, V; Morales-Peza, N | 1 |
| Garcia, EL; Mills, AA | 1 |
| Bingshun, W; Changhai, H; Ersheng, G; Exiang, Z; Jie, Y; Mauck, C; Youlun, G | 1 |
| Eid, MA; El Etreby, F; Kumar, MV; Lewis, RW; Liang, Y | 1 |
| Khosravi, S; Leung, PC | 1 |
| Barrett, JT; El Etreby, F; Hou, M; Kallab, AM; Liang, Y; Schoenlein, PV | 1 |
| An, BS; Choi, KC; Hong, EJ; Hwang, WS; Jeung, EB; Kang, SK; Lee, GS | 1 |
| Campana, A; Cheng, LN; Gülmezoglu, AM; Hofmeyr, GJ; Kulier, R | 2 |
| Nothnagle, M; Taylor, JS | 1 |
| Barrett, JT; Delk, JN; Gaddy, VT; Kallab, AM; Porter, AG; Schoenlein, PV | 1 |
| Augustowska, K; Gregoraszczuk, EL; Krzysiek, J; Milewicz, T; Ryś, J; Sztefko, K | 1 |
| Cao, YJ; Duan, EK; Li, J; Liu, WM; Peng, S; Wang, L; Yang, YJ; Yuan, JG; Zhou, JX | 1 |
| Calaf, GM | 1 |
| Maguire, J; Mody, I | 1 |
| Casper, KB; Jones, K; McCarthy, KD | 1 |
| Billi, S; Farina, MG; Franchi, AM; Guadagnoli, T; Leguizamón, G; Ribeiro, ML; Weissmann, C | 1 |
| Barrett, JT; Gaddy, VT; Ganapathy, V; Hou, M; Johnson, M; Kallab, A; Lewis, J; Samaddar, JS; Schoenlein, PV; Thangaraju, M | 1 |
| Dalsgaard, T; Jensen, TG; Mikkelsen, JG; Moldt, B; Sharma, N | 1 |
| Chadwick, JG; Denner, LA; Molenda-Figueira, HA; Murphy, SD; Shea, KL; Siegal, NK; Tetel, MJ; Zhao, Y | 1 |
| Festa, E; Hunter, D; Jenab, S; Minerly, AE; Niyomchai, T; Quinones-Jenab, V; Sun, W; Weierstall, K; Weiner, J; Wu, HB | 1 |
| Cao, M; Chen, J; Dong, DD; He, X; Li, K; Liu, J; Yang, H; Ye, SR; Yie, SM | 1 |
| Chen, CT; Chen, FH; Chen, MR; Hsu, CH; Kao, VY; Lin, KM; Liu, SW; Wu, TC; Yu, HC | 1 |
| Pogun, S; Yararbas, G | 1 |
| Campana, A; Cheng, L; Gülmezoglu, AM; Hofmeyr, GJ; Kapp, N; Kulier, R | 1 |
| Dohn, MR; Huang, S; Jackson, WH; LeRoith, D; Marrero, M; Periyasamy-Thandavan, S; Schoenlein, PV; Singer, A; Takhar, S; Thangaraju, M; Welborn, AE | 1 |
| Bradley, AJ; Feay, N; Geiser, F; McAllan, BM | 1 |
| Metsis, M; Salumets, A; Simm, J; Suhorutshenko, M; Tamm-Rosenstein, K | 1 |
| Böhmer, FD; Kirches, E; Mawrin, C; Pachow, D; Petermann, A; Wallesch, M; Wilisch-Neumann, A | 1 |
| Bregonzio, C; de Di Nasso, EG; Gamboa, DF; Pennacchio, GE; Soaje, M; Valdez, SR | 1 |
| Cabral, FJ; Del Bianco Borges, B; Franci, CR; Lima, FB; Ota, FH | 1 |
| Blaustein, JD; Domínguez-Ordóñez, R; García-Juárez, M; Gómora-Arrati, P; González-Flores, O; Lima-Hernández, FJ | 1 |
| McNicholas, C; Zigler, RE | 1 |
| Gajewska, M; Sobolewska, A; Zielniok, K | 1 |
| Blaustein, JD; Domínguez-Ordóñez, R; Domínguez-Salazar, E; Etgen, AM; Garcia-Juárez, M; Gómora-Arrati, P; González-Flores, O; Lima-Hernández, FJ | 1 |
| Piccinno, M; Rizzo, A; Sciorsci, RL | 1 |
| Guan, HY; Wang, L; Zhang, W | 1 |
| Davies, JA; Dominguez-Monedero, A | 1 |
14 review(s) available for mifepristone and tamoxifen
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Steroid antagonists as nuclear receptor blockers.
Topics: Androgen Antagonists; Anilides; Animals; Estradiol; Estrogen Antagonists; Estrogens; Humans; Mifepristone; Nitriles; Polyunsaturated Alkamides; Rats; Receptors, Estrogen; Tamoxifen; Tosyl Compounds | 1992 |
Transcription activation by estrogen and progesterone receptors.
Topics: Amino Acid Sequence; Animals; Carrier Proteins; Gene Expression Regulation; Humans; Ligands; Mifepristone; Molecular Sequence Data; Phosphorylation; Promoter Regions, Genetic; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Retinoic Acid; Receptors, Thyroid Hormone; Regulatory Sequences, Nucleic Acid; Tamoxifen; Transcription Factors; Transcription, Genetic; Zinc Fingers | 1991 |
[Antiestrogens and normal human breast cell proliferation].
Topics: 17-Hydroxysteroid Dehydrogenases; Breast; Cell Division; Estradiol; Estrogen Antagonists; Humans; Mifepristone; Progestins; Promegestone; Receptors, Estrogen; Stereoisomerism; Tamoxifen | 1989 |
Effect of antihormones on endometrial receptors and protein secretion.
Topics: Endometrium; Female; Humans; Mifepristone; Proteins; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1993 |
Endocrine therapy in metastatic breast cancer.
Topics: Adult; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogen Antagonists; Estrogens; Female; Gonadotropin-Releasing Hormone; Growth Substances; Hormone Antagonists; Humans; Menopause; Middle Aged; Mifepristone; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Palliative Care; Progestins; Receptors, Estrogen; Receptors, Growth Factor; Receptors, Progesterone; Tamoxifen | 1998 |
Thoughts on tamoxifen resistant breast cancer. Are coregulators the answer or just a red herring?
Topics: Animals; Breast Neoplasms; Cell Division; DNA-Binding Proteins; Drug Resistance, Neoplasm; Estrogen Receptor Modulators; Female; Histone Acetyltransferases; Humans; Mifepristone; Nuclear Receptor Co-Repressor 2; Nuclear Receptor Coactivator 1; Receptors, Estrogen; Receptors, Progesterone; Repressor Proteins; Tamoxifen; Transcription Factors | 2000 |
Getting around lethality with inducible Cre-mediated excision.
Topics: Alleles; Anti-Bacterial Agents; Antineoplastic Agents; Base Sequence; Disease Models, Animal; Gene Transfer Techniques; Genetic Techniques; Hormone Antagonists; Integrases; Interferons; Mifepristone; Models, Genetic; Promoter Regions, Genetic; Tamoxifen; Tetracycline; Time Factors; Viral Proteins | 2002 |
Medical methods for first trimester abortion.
Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Tamoxifen | 2004 |
Medical methods for first trimester abortion.
Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Randomized Controlled Trials as Topic; Tamoxifen | 2004 |
Medical methods for first-trimester abortion.
Topics: Abortifacient Agents; Abortion, Induced; Alprostadil; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Tamoxifen; Treatment Outcome | 2004 |
Medical methods for first trimester abortion.
Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Randomized Controlled Trials as Topic; Tamoxifen | 2011 |
Unscheduled vaginal bleeding with progestin-only contraceptive use.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Desogestrel; Doxycycline; Estrogens; Female; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Medroxyprogesterone Acetate; Metrorrhagia; Mifepristone; Progestins; Tamoxifen; Tranexamic Acid | 2017 |
1 trial(s) available for mifepristone and tamoxifen
| Article | Year |
|---|---|
A randomized comparative study on mifepristone alone and in combination with tamoxifen for emergency contraception.
Topics: Adult; Contraceptives, Postcoital, Synthetic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Mifepristone; Placebos; Pregnancy; Safe Sex; Tamoxifen; Time Factors | 2002 |
119 other study(ies) available for mifepristone and tamoxifen
| Article | Year |
|---|---|
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug.
Topics: Antineoplastic Agents; Binding Sites; Biotransformation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochromes b5; Dose-Response Relationship, Drug; Escherichia coli; Humans; Molecular Structure; Oxidation-Reduction; Protein Binding; Quinolines; Thiophenes | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101).
Topics: Animals; Drug Discovery; Female; Hormone Antagonists; Humans; Mice; Ovarian Neoplasms; Rats; Receptors, Glucocorticoid; Swine; Swine, Miniature; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line.
Topics: Breast Neoplasms; Carcinoma; Cell Count; Cell Cycle; Cell Division; DNA, Neoplasm; Drug Combinations; Humans; Mifepristone; Osmolar Concentration; Tamoxifen; Tumor Cells, Cultured | 1992 |
Repression of the alpha-fetoprotein gene promoter by progesterone and chimeric receptors in the presence of hormones and antihormones.
Topics: alpha-Fetoproteins; Animals; Base Sequence; Cell Line; Chickens; Chimera; Chromosome Deletion; Genes; Humans; Mifepristone; Molecular Sequence Data; Mutation; Oligonucleotide Probes; Progesterone; Promegestone; Promoter Regions, Genetic; Receptors, Progesterone; Restriction Mapping; Tamoxifen; Transfection | 1990 |
Effects of antiestrogen versus antiprogestin on transformed and nontransformed steroid receptors.
Topics: Animals; Centrifugation, Density Gradient; Estrogen Antagonists; Female; Mifepristone; Molybdenum; Promegestone; Rabbits; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterus | 1991 |
Steroid hormones modulate the release of immunoreactive gonadotropin-releasing hormone from cultured human placental cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Activins; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Inhibins; Mifepristone; Placenta; Pregnancy; Progesterone; Radioimmunoassay; Receptors, Opioid; Tamoxifen | 1990 |
Treatment of breast cancer with different antiprogestins: preclinical and clinical studies.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Models, Animal; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Hormones; Humans; Middle Aged; Mifepristone; Organ Size; Rats; Receptors, Steroid; Tamoxifen | 1990 |
Regulation of non-pregnant human uterine contractility. Effect of antihormones.
Topics: Adult; Dinoprost; Female; Humans; Luteal Phase; Mifepristone; Tamoxifen; Uterine Contraction | 1990 |
Sex steroid hormone modulation of NADPH pathways in MCF-7 cells.
Topics: Breast Neoplasms; Cell Division; Drug Interactions; Estradiol; Glucosephosphate Dehydrogenase; Humans; Mifepristone; NADP; Norpregnadienes; Premedication; Promegestone; Tamoxifen; Tumor Cells, Cultured | 1990 |
Normal breast cells in culture. Effect of estrogens, progestins, and antiestrogens.
Topics: 17-Hydroxysteroid Dehydrogenases; Breast; Cell Division; Cells, Cultured; Epithelial Cells; Estradiol; Estrogens; Humans; In Vitro Techniques; Mifepristone; Progestins; Promegestone; Tamoxifen | 1990 |
Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cytosol; Drug Implants; Estrenes; Female; Follicle Stimulating Hormone; Goserelin; Injections, Subcutaneous; Luteinizing Hormone; Mammary Neoplasms, Experimental; Mifepristone; Progestins; Rats; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
Topics: Adult; Chorionic Gonadotropin; Drug Interactions; Endometrium; Estradiol; Female; Humans; Luteal Phase; Luteinizing Hormone; Mifepristone; Progesterone; Tamoxifen; Uterine Hemorrhage | 1989 |
Effect of steroids and antisteroids on human meningioma cells in primary culture.
Topics: DNA Replication; Estradiol; Humans; Meningeal Neoplasms; Meningioma; Mifepristone; Progesterone; Tamoxifen; Thyroid Hormones; Tumor Cells, Cultured | 1989 |
Cyclical changes in plasma renin during the oestrous cycle in the rat: synchronized effect of oestrogen and progesterone.
Topics: Animals; Estradiol; Estrenes; Estrus; Female; Mifepristone; Ovariectomy; Progesterone; Rats; Receptors, Progesterone; Renin; Tamoxifen; Time Factors | 1989 |
Comparative effects of 17 beta-estradiol, progestin R5020, tamoxifen and RU38486 on lactate dehydrogenase activity in MCF-7 human breast cancer cells.
Topics: Breast Neoplasms; Cell Line; Dexamethasone; Dihydrotestosterone; Estradiol; Estrenes; Female; Histocytochemistry; Humans; L-Lactate Dehydrogenase; Mifepristone; Norpregnadienes; Promegestone; Tamoxifen | 1989 |
Modulation of aromatase activity in human endometrial stromal cells by steroids, tamoxifen and RU 486.
Topics: Adult; Aromatase; Dexamethasone; Dose-Response Relationship, Drug; Endometrium; Estrenes; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mifepristone; Norethindrone; Progesterone; Progestins; Promegestone; Steroids; Tamoxifen; Testosterone; Time Factors | 1986 |
Effects of steroid hormones and antihormones in cultured cells.
Topics: Animals; Cell Division; Cells, Cultured; Cyproterone; Cyproterone Acetate; Dexamethasone; Diethylstilbestrol; Dihydrotestosterone; Estradiol; Estrenes; Glucocorticoids; Gonadal Steroid Hormones; L Cells; Mammary Neoplasms, Experimental; Mice; Mifepristone; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Tamoxifen; Thymoma | 1985 |
Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Drug Interactions; Estradiol; Estrenes; Estrogens; Estrone; Mammary Neoplasms, Experimental; Mifepristone; Organ Size; Progesterone; Rats; Tamoxifen | 1987 |
The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function.
Topics: DNA; Estradiol; Estrenes; Estrogen Antagonists; Estrogens; Glucocorticoids; HeLa Cells; Hormones; Humans; Mifepristone; Polyunsaturated Alkamides; Receptors, Estrogen; Receptors, Glucocorticoid; Tamoxifen; Transcription Factors; Transcription, Genetic; Transfection | 1988 |
Inhibition of hepatoma cell growth by a steroid anti-hormone.
Topics: Animals; Cell Division; Dexamethasone; Estrenes; Glucocorticoids; Lipids; Liver Neoplasms, Experimental; Mifepristone; Progesterone; Progestins; Tamoxifen; Tumor Cells, Cultured | 1988 |
Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
Topics: Animals; Cells, Cultured; Dexamethasone; Estradiol; Estrenes; Megestrol; Megestrol Acetate; Mifepristone; Pituitary Neoplasms; Progesterone; Prolactin; Rats; Rats, Inbred BUF; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Tamoxifen | 1987 |
A novel progesterone-induced messenger RNA in rabbit and human endometria. Cloning and sequence analysis of the complementary DNA.
Topics: Animals; Base Sequence; Clone Cells; Collodion; DNA; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Endometrium; Estradiol; Estrenes; Female; Humans; Injections; Mifepristone; Molecular Sequence Data; Molecular Weight; Nucleic Acid Hybridization; Pregnancy; Progesterone; Progestins; Rabbits; RNA, Messenger; Tamoxifen; Tissue Distribution | 1987 |
The chicken ovalbumin promoter is under negative control which is relieved by steroid hormones.
Topics: Animals; Cells, Cultured; Chickens; Chimera; DNA, Recombinant; Estrenes; Female; Gene Expression Regulation; Genes; Glucocorticoids; Mifepristone; Ovalbumin; Oviducts; Progesterone; Promoter Regions, Genetic; Tamoxifen | 1987 |
Hormonal control of female sexual behavior in the Japanese quail.
Topics: Animals; Coturnix; Estradiol; Estrenes; Female; Mifepristone; Ovariectomy; Progesterone; Quail; Sexual Behavior, Animal; Tamoxifen | 1987 |
Steroid hormones induce cell proliferation and specific protein synthesis in primary chick oviduct cultures.
Topics: Animals; Cell Division; Cells, Cultured; Chickens; Conalbumin; Egg Proteins; Electrophoresis, Polyacrylamide Gel; Estradiol; Estrenes; Female; Mifepristone; Ovalbumin; Oviducts; Progesterone; Tamoxifen | 1986 |
Hormonal manipulation of meningiomas in vitro.
Topics: Cells, Cultured; Estradiol; Estrenes; Humans; Meningeal Neoplasms; Meningioma; Mifepristone; Progesterone; Tamoxifen | 1986 |
Recent developments regarding steroid receptors and antihormones.
Topics: Animals; Chemical Phenomena; Chemistry; Chickens; Drug Synergism; Estrenes; Estrus; Female; Hormone Antagonists; Mifepristone; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Tamoxifen | 1986 |
Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells.
Topics: Breast Neoplasms; Cell Survival; Estradiol; Estrenes; Estrogen Antagonists; Female; Humans; Mifepristone; Progestins; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1987 |
Mechanism of action of an antiprogesterone, RU486, in the rabbit endometrium. Effects of RU486 on the progesterone receptor and on the expression of the uteroglobin gene.
Topics: Animals; Antibodies, Monoclonal; Chemical Phenomena; Chemistry; DNA; Endometrium; Estradiol; Estrenes; Female; Gene Expression Regulation; Glycoproteins; Mifepristone; Rabbits; Receptors, Progesterone; RNA, Messenger; Tamoxifen; Uteroglobin | 1985 |
Anti-steroid action in cultured L-929 mouse fibroblasts.
Topics: Animals; Cell Adhesion; Cell Division; Centrifugation, Density Gradient; Dexamethasone; Estradiol; Estrenes; Estrogen Antagonists; Fibroblasts; Mice; Mifepristone; Receptors, Estrogen; Receptors, Glucocorticoid; Tamoxifen | 1984 |
Role of 17 beta-estradiol and progesterone in the regulation of synthesis and secretion of chorionic gonadotropin by the first trimester human placenta.
Topics: Androstatrienes; Chorionic Gonadotropin; Estradiol; Female; Gene Expression; Humans; In Vitro Techniques; Mifepristone; Placenta; Pregnancy; Pregnancy Trimester, Third; Progesterone; RNA, Messenger; Tamoxifen; Transcription, Genetic | 1995 |
Effect of RU486 on ovarian progesterone production at pro-oestrus and during pregnancy: a possible dual regulation of the biosynthesis of progesterone.
Topics: 3-Hydroxysteroid Dehydrogenases; Animals; Corpus Luteum; Estradiol; Female; Luteinizing Hormone; Mifepristone; Ovary; Pregnancy; Proestrus; Progesterone; Prolactin; Rats; Rats, Wistar; Stimulation, Chemical; Tamoxifen | 1994 |
Inappropriate ovarian feedback in basal gonadotropin secretion in 4-day cyclic rat treated with mifepristone: role of endogenous estradiol.
Topics: Animals; Circadian Rhythm; Dose-Response Relationship, Drug; Estradiol; Feedback; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropins; Luteinizing Hormone; Mifepristone; Ovariectomy; Ovary; Progesterone; Radioimmunoassay; Rats; Rats, Wistar; Tamoxifen; Testosterone; Time Factors | 1994 |
Interaction between steroid hormones and endometrial opioids.
Topics: Adenocarcinoma; Animals; beta-Endorphin; Blotting, Northern; Dexamethasone; Dynorphins; Endometrial Neoplasms; Estradiol; Female; Hormones; Humans; Male; Mifepristone; Potassium Chloride; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured | 1994 |
Steroid hormone receptors in three human gastric cancer cell lines.
Topics: Adenocarcinoma; Animals; Cell Cycle; Estradiol; Flow Cytometry; Humans; Hydrocortisone; Male; Mice; Mice, Inbred ICR; Mice, Nude; Mifepristone; Neoplasm Transplantation; Progesterone; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Stomach Neoplasms; Tamoxifen; Tumor Cells, Cultured | 1994 |
Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cells.
Topics: Cell Division; Cystadenocarcinoma, Serous; DNA, Antisense; Estradiol; Female; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Mifepristone; Neoplasm Proteins; Ovarian Neoplasms; Proto-Oncogene Mas; Receptors, Estrogen; Tamoxifen; Transcription, Genetic; Tumor Cells, Cultured | 1994 |
The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study.
Topics: 17-Hydroxysteroid Dehydrogenases; Adult; Down-Regulation; Endometrium; Female; Humans; Immunohistochemistry; Luteal Phase; Mifepristone; Radioimmunoassay; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Tamoxifen | 1993 |
Correlation of growth hormone secretion during pregnancy with circulating prolactin in rats.
Topics: Animals; Female; Growth Hormone; Mifepristone; Ovariectomy; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Rats; Rats, Wistar; Stress, Physiological; Tamoxifen | 1993 |
Isolation of pMGT1: a gene that is repressed by oestrogen and increased by antioestrogens and antiprogestins.
Topics: Breast Neoplasms; DNA, Neoplasm; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Tumor Cells, Cultured | 1993 |
Effect of tamoxifen alone and in combination with RU 486 on the endometrium in the mid-luteal phase.
Topics: Embryo Implantation; Endometrium; Estrogens; Female; Glycodelin; Glycoproteins; Hormones; Humans; Luteal Phase; Luteinizing Hormone; Mifepristone; Pregnancy Proteins; Progesterone; Receptors, Steroid; Secretory Rate; Tamoxifen | 1993 |
Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions.
Topics: Amino Acid Sequence; Animals; Estradiol; Estrus; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Mifepristone; Molecular Sequence Data; Ovariectomy; Ovary; Progesterone; Rats; Rats, Wistar; Tamoxifen; Testosterone | 1993 |
Response of human ovarian carcinoma cell lines to antiprogestin mifepristone.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Hormone Antagonists; Humans; Mifepristone; Ovarian Neoplasms; Paclitaxel; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured | 1996 |
The effects of the antihormones RU486 and tamoxifen on fetoplacental development and placental bed vascularisation in the rat: a model for intrauterine fetal growth retardation.
Topics: Abortifacient Agents, Steroidal; Animals; Body Weight; Embryo Implantation; Embryonic and Fetal Development; Estrogen Antagonists; Female; Immunohistochemistry; Mifepristone; Placenta; Placentation; Pregnancy; Rats; Rats, Wistar; Tamoxifen | 1996 |
Tamoxifen and RU39411 synergize with mifepristone to produce preimplantation pregnancy loss by increasing embryo transport (rat).
Topics: Abortifacient Agents, Steroidal; Administration, Oral; Animals; Blastocyst; Corpus Luteum; Drug Combinations; Drug Synergism; Embryo Implantation; Embryo Loss; Embryonic Development; Estradiol; Estrogen Antagonists; Female; Mifepristone; Pregnancy; Rats; Rats, Wistar; Tamoxifen; Time Factors | 1996 |
Effects of sex- and glucocorticoid steroids on breast cancer cells grown as either multicellular tumor spheroids or monolayers.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Dexamethasone; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Humans; Medroxyprogesterone Acetate; Mifepristone; Spheroids, Cellular; Steroids; Tamoxifen; Tumor Cells, Cultured | 1996 |
Effect of hormones and antihormones on phospholipase A2 activity in human endometrial stromal cells.
Topics: Analysis of Variance; Endometrium; Estradiol; Estrogen Antagonists; Female; Hormone Antagonists; Humans; In Vitro Techniques; Mifepristone; Phospholipases A; Phospholipases A2; Progesterone; Stromal Cells; Tamoxifen | 1996 |
Anti-implantation activity of antiestrogens and mifepristone.
Topics: Administration, Oral; Animals; Contraceptives, Postcoital; Embryo Implantation; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Injections, Subcutaneous; Male; Mifepristone; Norandrostanes; Pregnancy; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 1996 |
RU486-treated rats show endocrine and morphological responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies.
Topics: Androgen Antagonists; Animals; Bromocriptine; Disease Models, Animal; Dopamine Agonists; Estrogen Antagonists; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Mifepristone; Ovary; Ovulation; Polycystic Ovary Syndrome; Progesterone; Rats; Rats, Wistar; Tamoxifen | 1996 |
The influence of estrogens, progesterone and their antagonists on the collagen content in the pregnant rat uterus.
Topics: Animals; Collagen; Estradiol; Female; Hormone Antagonists; Mifepristone; Pregnancy; Progesterone; Rats; Rats, Wistar; Tamoxifen; Uterus | 1996 |
Effect of mifepristone and antiestrogens on uterine PGF2 alpha and PGE2 concentrations in ovariectomized and pregnant rats.
Topics: Abortifacient Agents, Steroidal; Animals; Contraceptives, Postcoital, Synthetic; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Embryonic Development; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Mifepristone; Norandrostanes; Organ Size; Ovariectomy; Pregnancy; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 1997 |
In vivo antiestrogenic activity of mifepristone in the rat.
Topics: Animals; Body Weight; Corticosterone; Drug Combinations; Estradiol; Estrogen Antagonists; Injections, Subcutaneous; Male; Mifepristone; Organ Size; Pituitary Gland, Anterior; Rats; Rats, Wistar; Tamoxifen | 1997 |
Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays.
Topics: Adenocarcinoma; Alkaline Phosphatase; Androgen Antagonists; Androgens; Breast Neoplasms; Cyproterone Acetate; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Flutamide; Gonanes; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Testosterone; Testosterone Congeners; Tumor Cells, Cultured | 1997 |
Opioidergic regulation of prolactin secretion during pregnancy: role of ovarian hormones.
Topics: Animals; Estradiol; Estrogen Antagonists; Female; Gestational Age; Hormone Antagonists; Mifepristone; Naloxone; Narcotic Antagonists; Opioid Peptides; Pregnancy; Progesterone; Prolactin; Rats; Rats, Wistar; Tamoxifen | 1997 |
Release of prorenin and placental hormones from superfused minced chorion laeve.
Topics: Analysis of Variance; Angiotensin II; Cesarean Section; Chorion; Diltiazem; Enzyme Precursors; Estradiol; Female; Humans; In Vitro Techniques; Mifepristone; Placenta; Pregnancy; Progesterone; Renin; Tamoxifen | 1997 |
Tamoxifen-mediated anti-cellular effect against a choriocarcinoma cell line.
Topics: Cell Line; Cell Survival; Choriocarcinoma; Estrogen Antagonists; Female; Hormone Antagonists; Humans; Kinetics; Mifepristone; Pregnancy; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Trophoblasts; Uterine Neoplasms | 1998 |
A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.
Topics: Animals; Binding Sites; Cell Line; Chlorocebus aethiops; Humans; Kidney; Ligands; Mice; Mifepristone; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Peptides; Progesterone; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Receptors, Steroid; Receptors, Thyroid Hormone; Repressor Proteins; Tamoxifen; Transcription, Genetic; Transcriptional Activation | 1998 |
Sex steroid hormones modulate the activation of murine peritoneal macrophages: receptor mediated modulation.
Topics: Animals; Castration; Cyproterone Acetate; Estradiol; Female; Flutamide; Gonadal Steroid Hormones; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Mifepristone; Nitrites; Progesterone; Receptors, Steroid; Tamoxifen; Testosterone | 1998 |
Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude mice.
Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Gonanes; Hormone Antagonists; Humans; Mice; Mice, Nude; Mifepristone; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured | 1998 |
Effects of estradiol and progesterone on cytochrome P4501A1 expression in Hepa 1c1c7 cells.
Topics: Animals; Cytochrome P-450 CYP1A1; Dioxins; DNA, Complementary; Enhancer Elements, Genetic; Enzyme Induction; Estradiol; Estrogen Antagonists; Hormone Antagonists; Mice; Mifepristone; Progesterone; Receptors, Aryl Hydrocarbon; Regulatory Sequences, Nucleic Acid; RNA, Messenger; Tamoxifen; Transcriptional Activation; Tumor Cells, Cultured | 1998 |
Role of carboxy-extended forms of oxytocin in the rat uterus in the process of parturition.
Topics: Animals; Estrogen Antagonists; Female; Gestational Age; Hormone Antagonists; Labor, Obstetric; Mifepristone; Oxytocin; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin; Tamoxifen; Uterus | 1998 |
Estrogen-induced hepatic toxicity and hepatic cancer: differences between two closely related hamster species.
Topics: Adenoma, Liver Cell; Animals; Bilirubin; Carcinoma, Hepatocellular; Cricetinae; Cricetulus; Diethylstilbestrol; Estrogens; Female; Inclusion Bodies; Liver; Liver Neoplasms, Experimental; Male; Medroxyprogesterone Acetate; Mifepristone; Species Specificity; Tamoxifen; Zeranol | 1998 |
Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen.
Topics: Alitretinoin; Animals; Anticarcinogenic Agents; Apoptosis; Benzoates; Bexarotene; Breast Neoplasms; Cell Division; Disease Models, Animal; Female; Fenretinide; Hormone Antagonists; Humans; Mammary Neoplasms, Animal; Mice; Mice, Inbred C57BL; Mifepristone; Retinoids; Tamoxifen; Tetrahydronaphthalenes; Tretinoin; Tumor Cells, Cultured | 1998 |
Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells.
Topics: Apoptosis; Blotting, Western; Breast Neoplasms; DNA Fragmentation; Down-Regulation; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Estrogen Antagonists; Female; Hormone Antagonists; Humans; Mifepristone; Neoplasms, Hormone-Dependent; Protein Kinase C; Proto-Oncogene Proteins c-bcl-2; Tamoxifen; Transforming Growth Factor beta; Tumor Cells, Cultured | 1998 |
Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone.
Topics: Blotting, Northern; Cells, Cultured; Chemokine CCL2; Endometrium; Estradiol; Estrogen Antagonists; Female; Gene Expression Regulation; Hormone Antagonists; Humans; Mifepristone; Progesterone; RNA, Messenger; Stromal Cells; Tamoxifen | 1999 |
Peptide antagonists of the human estrogen receptor.
Topics: Amino Acid Sequence; Binding Sites; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Humans; Ligands; Mifepristone; Molecular Sequence Data; Peptide Library; Peptides; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Recombinant Fusion Proteins; Tamoxifen; Transcription Factor AP-1; Transcription, Genetic | 1999 |
Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Survival; Ceramides; Doxorubicin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Estrogen Antagonists; Female; Hormone Antagonists; Humans; Mifepristone; Tamoxifen; Tumor Cells, Cultured | 1999 |
Reduced expression of endothelial and inducible nitric oxide synthase in a human breast cancer cell line which has acquired estrogen independence.
Topics: Animals; Breast Neoplasms; Cattle; Estrogens; Female; Humans; Immunohistochemistry; Mifepristone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Progesterone; Rabbits; Tamoxifen; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1999 |
Effects of anordrin, droloxifene, nomegestrol, and mifepristone on cultured rat luteal cell apoptosis.
Topics: Animals; Apoptosis; Cell Survival; Cells, Cultured; Contraceptives, Oral, Synthetic; Corpus Luteum; Estrogen Antagonists; Female; Luteolytic Agents; Megestrol; Mifepristone; Norandrostanes; Progesterone Congeners; Rats; Rats, Sprague-Dawley; Tamoxifen | 1999 |
Attenuated hypotensive response to proadrenomedullin N-terminal 20 peptide in pregnant rats: modulation by steroid hormones.
Topics: Adrenomedullin; Animals; Blood Pressure; Dose-Response Relationship, Drug; Estradiol; Female; Hormone Antagonists; Hypotension; Mifepristone; Ovariectomy; Peptide Fragments; Peptides; Pregnancy; Pregnancy, Animal; Progesterone; Proteins; Rats; Rats, Wistar; Tamoxifen; Time Factors | 1999 |
Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture.
Topics: Animals; Antibodies; Apoptosis; Cell Division; Cell Survival; DNA Fragmentation; Estrogen Antagonists; Hormone Antagonists; Humans; Male; Mannosephosphates; Mice; Mice, Nude; Mifepristone; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tamoxifen; Transforming Growth Factor beta; Tumor Cells, Cultured | 2000 |
Estrogen and progesterone modulation of eosinophilic infiltration of the rat uterine cervix.
Topics: Animals; Cervical Ripening; Cervix Uteri; Chemotaxis, Leukocyte; Dactinomycin; Eosinophils; Estrogen Antagonists; Estrogens; Female; Mifepristone; Nucleic Acid Synthesis Inhibitors; Ovariectomy; Pregnancy; Progesterone; Pseudopregnancy; Rats; Rats, Wistar; Tamoxifen | 2000 |
Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism.
Topics: Amantadine; Animals; Antidepressive Agents; Cell Line, Transformed; Chloramphenicol O-Acetyltransferase; Cocaine; Corticosterone; Cyclic AMP; Cyclic GMP; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Estrenes; Gene Expression Regulation; Imipramine; Lithium Chloride; Memantine; Mifepristone; Protein Kinase Inhibitors; Pyrrolidinones; Receptors, Glucocorticoid; Receptors, Steroid; Sulfonamides; Tamoxifen; Thionucleotides; Time Factors; Transcription, Genetic; Type C Phospholipases | 2000 |
Luteinizing hormone secretion elicited in a ligand-independent activation of progesterone receptor manner at pituitary level in the rat: differential effect of two selective estrogen receptor modulators.
Topics: Animals; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Mifepristone; Pituitary Gland, Anterior; Pregnancy; Prolactin; Raloxifene Hydrochloride; Rats; Rats, Wistar; Receptors, Progesterone; Tamoxifen | 2000 |
Effect of neonatal treatment with mifepristone or tamoxifen on the binding capacity of the thymic glucocorticoid or uterine estrogen receptor of adult rats: data on the mechanism of hormonal imprinting.
Topics: Animals; Animals, Newborn; Dexamethasone; Estradiol; Female; Genomic Imprinting; Hormone Antagonists; Injections, Subcutaneous; Male; Mifepristone; Rats; Rats, Wistar; Receptors, Estrogen; Receptors, Glucocorticoid; Signal Transduction; Tamoxifen; Thymus Gland; Uterus | 2000 |
Effect of mifepristone approval on research remains to be seen.
Topics: Abortifacient Agents, Steroidal; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Drug Approval; Drug Industry; Female; France; Germany; Humans; Male; Mifepristone; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Progesterone; Prostatic Neoplasms; Research Support as Topic; Tamoxifen; United States; United States Food and Drug Administration | 2000 |
Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins.
Topics: Apoptosis; DNA-Binding Proteins; Dose-Response Relationship, Drug; Estrogens; HeLa Cells; Humans; Hydroxyestrones; Indoles; Mifepristone; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus E7 Proteins; Progesterone; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 2001 |
Progestins block cholesterol synthesis to produce meiosis-activating sterols.
Topics: Animals; Body Weight; Cholestadienols; Cholesterol; Estrogen Antagonists; Humans; Hydroxyprogesterones; Male; Meiosis; Miconazole; Mifepristone; Progestins; Rats; Spectrum Analysis; Sterols; Tamoxifen; Testis; Tumor Cells, Cultured | 2001 |
The effect of a single neonatal treatment (hormonal imprinting) with the antihormones, tamoxifen and mifepristone on the sexual behavior of adult rats.
Topics: Animals; Animals, Newborn; Copulation; Ejaculation; Estrogen Antagonists; Female; Hormone Antagonists; Injections, Subcutaneous; Male; Mifepristone; Ovariectomy; Posture; Progesterone; Rats; Rats, Wistar; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Sexual Behavior, Animal; Tamoxifen | 2001 |
Differential expression of members of the tumor necrosis factor alpha-related apoptosis-inducing ligand pathway in prostate cancer cells.
Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Humans; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Nude; Mifepristone; Prostatic Neoplasms; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Signal Transduction; Tamoxifen; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2001 |
Regulation by endogenous opioids of suckling-induced prolactin secretion in pregnant and lactating rats: role of ovarian steroids.
Topics: Animals; Estrogen Antagonists; Female; Hormone Antagonists; Lactation; Maternal Behavior; Mifepristone; Naloxone; Narcotic Antagonists; Pregnancy; Progesterone; Prolactin; Rats; Rats, Wistar; Tamoxifen | 2002 |
In vivo tissue-specific regulation of the human papillomavirus type 18 early promoter by estrogen, progesterone, and their antagonists.
Topics: Animals; beta-Galactosidase; Cervix Uteri; Epithelium; Estradiol; Estrous Cycle; Female; Gene Expression Regulation, Viral; Hormone Antagonists; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Mifepristone; Ovariectomy; Papillomaviridae; Pregnancy; Progesterone; Promoter Regions, Genetic; Tamoxifen; Transgenes; Vagina; Viral Proteins | 2002 |
Messenger RNA for progesterone receptor isoforms in the late-gestation rat uterus.
Topics: Animals; Female; Gestational Age; Hormone Antagonists; Mifepristone; Pregnancy; Progesterone; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; RNA, Messenger; Tamoxifen; Uterus | 2002 |
Mifepristone-induced secretion of transforming growth factor beta1-induced apoptosis in prostate cancer cells.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Cell Survival; Cytochrome c Group; Cytosol; Enzyme-Linked Immunosorbent Assay; Estrogen Antagonists; Fluorescent Dyes; Humans; Immunoblotting; Male; Mice; Mice, Nude; Mifepristone; Prostatic Neoplasms; Rhodamines; Tamoxifen; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |
Differential regulation of gonadotropin-releasing hormone (GnRH)I and GnRHII messenger ribonucleic acid by gonadal steroids in human granulosa luteal cells.
Topics: Cells, Cultured; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Gene Expression Regulation; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Luteal Cells; Mifepristone; Progesterone; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tamoxifen | 2003 |
Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
Topics: Apoptosis; Breast Neoplasms; Caspases; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cytochromes c; Drug Synergism; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Mifepristone; Receptors, Estrogen; Retinoblastoma Protein; Tamoxifen; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured; Tumor Suppressor Proteins; Up-Regulation | 2003 |
Mouse calbindin-D(9k) gene expression in the uterus during late pregnancy and lactation.
Topics: Animals; Calbindins; Estrogen Receptor alpha; Female; Gene Expression Profiling; Gene Expression Regulation; Lactation; Male; Mice; Mifepristone; Pregnancy; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; S100 Calcium Binding Protein G; Tamoxifen | 2003 |
Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
Topics: Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Cell Proliferation; Coloring Agents; DNA Fragmentation; Drug Resistance, Neoplasm; Enzyme Activation; Estradiol; Estrogen Receptor Modulators; Fulvestrant; G1 Phase; Hormone Antagonists; Humans; Immunoblotting; Mifepristone; Phosphorylation; Receptors, Estrogen; Receptors, Progesterone; Resting Phase, Cell Cycle; Tamoxifen; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
Topics: Breast Neoplasms; Drug Synergism; Estradiol; Female; Humans; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Mifepristone; Neoplasms, Hormone-Dependent; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tissue Culture Techniques | 2005 |
Expression and hormonal regulation of calcyclin-binding protein (CacyBP) in the mouse uterus during early pregnancy.
Topics: Animals; Apoptosis; Calcium-Binding Proteins; Cells, Cultured; Decidua; Drug Antagonism; Estradiol; Female; Gene Expression Regulation; Mice; Mifepristone; Oligonucleotides, Antisense; Ovariectomy; Pregnancy; Progesterone; Pseudopregnancy; RNA, Messenger; Stromal Cells; Tamoxifen; Trophoblasts; Uterus | 2006 |
Susceptibility of human breast epithelial cells in vitro to hormones and drugs.
Topics: Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Proliferation; Epithelial Cells; Estradiol; Estrogen Antagonists; Female; Humans; Mifepristone; Organ Culture Techniques; Progesterone; Progestins; Tamoxifen | 2006 |
Neurosteroid synthesis-mediated regulation of GABA(A) receptors: relevance to the ovarian cycle and stress.
Topics: Animals; Corticosterone; Desoxycorticosterone; Female; Finasteride; Hippocampus; Male; Menstrual Cycle; Mice; Mice, Inbred C57BL; Mifepristone; Neuronal Plasticity; Patch-Clamp Techniques; Progesterone; Receptors, GABA-A; Receptors, Progesterone; Stress, Physiological; Tamoxifen | 2007 |
Characterization of astrocyte-specific conditional knockouts.
Topics: Animals; Astrocytes; Base Sequence; Cell Line; DNA Primers; Estrogen Receptor Modulators; Glial Fibrillary Acidic Protein; Hormone Antagonists; Humans; Mice; Mice, Knockout; Mice, Transgenic; Mifepristone; Neurons; Oligodendroglia; Promoter Regions, Genetic; Recombination, Genetic; Tamoxifen; Tetracycline | 2007 |
Secretory and cytosolic phospholipase A2 activities and expression are regulated by oxytocin and estradiol during labor.
Topics: Animals; Cytosol; Dinoprost; Estradiol; Estrogen Antagonists; Female; Gene Expression; Isoenzymes; Labor, Obstetric; Mifepristone; Oxytocin; Phospholipases A2; Pregnancy; Progesterone; Rats; Rats, Wistar; Receptors, Oxytocin; Reverse Transcriptase Polymerase Chain Reaction; Tamoxifen; Uterus; Vasotocin | 2007 |
Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; DNA Fragmentation; Down-Regulation; Estrogen Antagonists; Estrogens; Gene Expression Regulation, Neoplastic; Humans; Mifepristone; Retinoblastoma Protein; RNA, Small Interfering; Tamoxifen | 2007 |
Regulated gene insertion by steroid-induced PhiC31 integrase.
Topics: Animals; Bacteriophages; Cell Line; DNA Nucleotidyltransferases; Gene Transfer Techniques; Humans; Integrases; Mice; Mifepristone; Protein Structure, Tertiary; Receptors, Estrogen; Receptors, Progesterone; Recombinant Fusion Proteins; Tamoxifen; Transposases | 2008 |
Steroid receptor coactivator-1 from brain physically interacts differentially with steroid receptor subtypes.
Topics: Animals; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Glutathione Transferase; Hippocampus; Histone Acetyltransferases; Hormone Antagonists; Hypothalamus; Ligands; Mass Spectrometry; Mifepristone; Nuclear Receptor Coactivator 1; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Recombinant Proteins; Tamoxifen; Transcription Factors | 2008 |
Effects of RU 486 and tamoxifen on cocaine-induced behavioral and endocrinologic activations in male and female Fischer rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cocaine; Corticosterone; Dose-Response Relationship, Drug; Female; Hormone Antagonists; Hypothalamo-Hypophyseal System; Male; Mifepristone; Progesterone; Rats; Rats, Inbred F344; Sex Factors; Tamoxifen | 2008 |
HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro.
Topics: Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Histocompatibility Antigens Class I; HLA Antigens; HLA-G Antigens; Hormone Antagonists; Hormones; Humans; Immunoenzyme Techniques; In Vitro Techniques; Middle Aged; Mifepristone; Neoplasm Staging; Progesterone; Prognosis; Survival Rate; T-Lymphocytes, Cytotoxic; Tamoxifen; Tumor Cells, Cultured | 2010 |
RU486-inducible recombination in the salivary glands of lactoferrin promoter-driven green fluorescent Cre transgenic mice.
Topics: Animals; Estradiol; Genes, Reporter; Genetic Vectors; Green Fluorescent Proteins; Humans; Integrases; Lac Operon; Lactoferrin; Luciferases, Firefly; Mice; Mice, Transgenic; Mifepristone; Progesterone; Promoter Regions, Genetic; Receptors, Progesterone; Recombinant Fusion Proteins; Recombination, Genetic; Salivary Glands; Tamoxifen; Transfection | 2010 |
Tamoxifen and mifepriston modulate nicotine induced conditioned place preference in female rats.
Topics: Animals; Conditioning, Psychological; Female; Hormone Antagonists; Humans; Male; Mifepristone; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Smoking Cessation; Tamoxifen; Tobacco Use Disorder | 2011 |
Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Breast Neoplasms; Cell Line, Tumor; Enzyme Inhibitors; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Hormone Antagonists; Humans; Insulin-Like Growth Factor I; MAP Kinase Kinase 1; Membrane Proteins; Mifepristone; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptors, Estrogen; Tamoxifen | 2012 |
The influence of reproductive hormones on the torpor patterns of the marsupial Sminthopsis macroura: bet-hedging in an unpredictable environment.
Topics: Adaptation, Physiological; Animals; Basal Metabolism; Body Temperature; Body Temperature Regulation; Body Weight; Circadian Rhythm; Estrogens; Female; Flutamide; Hormone Antagonists; Male; Marsupialia; Mifepristone; Photoperiod; Progesterone; Reproduction; Tamoxifen; Testosterone | 2012 |
Changes in the transcriptome of the human endometrial Ishikawa cancer cell line induced by estrogen, progesterone, tamoxifen, and mifepristone (RU486) as detected by RNA-sequencing.
Topics: Cell Line, Tumor; Endometrial Neoplasms; Estrogens; Female; Gene Expression Profiling; GTP-Binding Proteins; Humans; Membrane Proteins; Mifepristone; Mitochondrial Proteins; Neoplasm Proteins; Progesterone; Receptors for Activated C Kinase; Receptors, Cell Surface; Tamoxifen; Transcriptome | 2013 |
Practice bulletin no. 143: medical management of first-trimester abortion.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Clinical Protocols; Directive Counseling; Drug Administration Schedule; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Patient Selection; Pregnancy; Pregnancy Trimester, First; Tamoxifen | 2014 |
Re-evaluation of cytostatic therapies for meningiomas in vitro.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Erlotinib Hydrochloride; Humans; Hydroxyurea; Losartan; Meningeal Neoplasms; Meningioma; Metformin; Mifepristone; Neurofibromin 2; Promoter Regions, Genetic; Quinazolines; Radiation Tolerance; Tamoxifen; Temozolomide; Tumor Suppressor Proteins; Verapamil | 2014 |
Opioid modulation of prolactin secretion induced by stress during late pregnancy. Role of ovarian steroids.
Topics: Analgesics, Opioid; Animals; Estradiol; Female; Mifepristone; Naloxone; Naltrexone; Narcotic Antagonists; Ovary; Pregnancy; Progesterone; Prolactin; Rats; Rats, Wistar; Steroids; Tamoxifen | 2014 |
Estrogen, but not progesterone, induces the activity of nitric oxide synthase within the medial preoptic area in female rats.
Topics: Animals; Estradiol; Estrogen Antagonists; Estrous Cycle; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Mifepristone; Nitric Oxide Synthase; Preoptic Area; Progesterone; Rats; Rats, Wistar; Tamoxifen | 2014 |
Sexual receptivity facilitated by unesterified estradiol: Dependence on estrogen and progestin receptors and priming dose of estradiol benzoate.
Topics: Animals; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Hormone Antagonists; Mifepristone; Oligonucleotides, Antisense; Ovariectomy; Posture; Psychotropic Drugs; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Sexual Behavior, Animal; Tamoxifen; Time Factors | 2015 |
Mechanisms of autophagy induction by sex steroids in bovine mammary epithelial cells.
Topics: Animals; Autophagy; Autophagy-Related Protein 5; Beclin-1; Cattle; Cell Line; Culture Media; Epithelial Cells; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation; Mammary Glands, Animal; Microtubule-Associated Proteins; Mifepristone; Phosphorylation; Progesterone; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tamoxifen | 2017 |
Lordosis facilitated by GPER-1 receptor activation involves GnRH-1, progestin and estrogen receptors in estrogen-primed rats.
Topics: Animals; Estradiol; Female; Hormone Antagonists; Mifepristone; Oligopeptides; Posture; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, G-Protein-Coupled; Receptors, LHRH; Receptors, Progesterone; Sexual Behavior, Animal; Tamoxifen | 2018 |
Contractile effect of rifaximin on bovine uterus in the presence of steroid hormone antagonists.
Topics: Animals; Cattle; Cells, Cultured; Estrogens; Female; Gonadal Steroid Hormones; Hormone Antagonists; Luteal Phase; Mifepristone; Organ Culture Techniques; Progesterone; Rifamycins; Rifaximin; Tamoxifen; Uterine Contraction; Uterus | 2018 |
Decay-accelerating factor promotes endometrial cells proliferation and motility under ovarian hormone stimulation.
Topics: Adult; CD55 Antigens; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Endometrium; Estradiol; Female; Humans; Mifepristone; Progesterone; Stromal Cells; Tamoxifen | 2018 |
Tamoxifen- and Mifepristone-Inducible Versions of CRISPR Effectors, Cas9 and Cpf1.
Topics: Bacterial Proteins; Clustered Regularly Interspaced Short Palindromic Repeats; CRISPR-Associated Protein 9; Endonucleases; Gene Editing; Gene Expression; Genes, Reporter; HEK293 Cells; Humans; Mifepristone; Mutagenesis; Plasmids; Receptors, Estrogen; Recombinant Fusion Proteins; RNA, Guide, Kinetoplastida; Tamoxifen | 2018 |